Express Scripts (ESRX) Becomes Part of Qsymia Home Delivery Network (VVUS)
Tweet
Share
E-mailGet Alerts VVUS Hot Sheet
Join SI Premium – FREE
VIVUS, Inc. (Nasdaq: VVUS) announced that Express Scripts (Nasdaq: ESRX), the country's largest Pharmacy Benefit Manager (PBM), has joined the Qsymia Certified Home Delivery Pharmacy Network.
Qsymia is available only through mail order from the Qsymia Certified Home Delivery Pharmacy Network, including CVS Pharmacy, Walgreens and now Express Scripts, as part of the Qsymia Risk Evaluation and Mitigation Strategy (REMS) program. Contact information for the certified pharmacies can be found on www.Qsymia.com and www.QsymiaREMS.com.
Qsymia was made available September 17, 2012 and is the first FDA-approved once daily combination therapy — and the first new medication available in 13 years — for the treatment of obesity.
Qsymia is available only through mail order from the Qsymia Certified Home Delivery Pharmacy Network, including CVS Pharmacy, Walgreens and now Express Scripts, as part of the Qsymia Risk Evaluation and Mitigation Strategy (REMS) program. Contact information for the certified pharmacies can be found on www.Qsymia.com and www.QsymiaREMS.com.
Qsymia was made available September 17, 2012 and is the first FDA-approved once daily combination therapy — and the first new medication available in 13 years — for the treatment of obesity.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sky Quarry names Heidi Bowman as CFO
- Scholar Rock updates apitegromab regulatory status in U.S., Europe, Japan
- Nvidia makes minority investment in Cloverleaf Infrastructure
Create E-mail Alert Related Categories
Corporate News, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
